Ticker Details
Revolution Medicines, Inc.
IPO Date:	February 13, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$40.63B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.12 | 2.93%
Avg Daily Range (30 D):	$4.43 | 2.65%
Avg Daily Range (90 D):	$3.56 | 2.61%

Institutional Daily Volume
Avg Daily Volume:	1.05M
Avg Daily Volume (30 D):	2.57M
Avg Daily Volume (90 D):	2.38M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	6,565
Avg Institutional Trade:	$4.85M
Avg Institutional Trade (30 D):	$15.83M
Avg Institutional Trade (90 D):	$12.18M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$11.04M
Avg Closing Trade (30 D):	$92.27M
Avg Closing Trade (90 D):	$65.45M
Avg Closing Volume:	209.12K

News

Jul 6, 2026 @ 10:10 PM These 3 Stocks Trounced the S&P 500 in the First H... Source: Adria Cimino

Jul 6, 2026 @ 8:43 PM Erasca (ERAS) Faces Securities Class Action After ... Source: Hagens Berman Shareholder Rights Law Firm

Jul 5, 2026 @ 11:15 PM Revolution Medicines Is Up Nearly 140% in 2026. Is... Source: Adria Cimino

Jul 3, 2026 @ 6:19 PM Erasca, Inc. (ERAS) Faces Securities Class Action ... Source: Hagens Berman

Jul 2, 2026 @ 8:55 PM INVESTOR ALERT: Erasca, Inc. (NASDAQ: ERAS) Invest... Source: Robbins Geller Rudman & Dowd Llp

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-7.1	$-2.29	$-1.89
Diluted EPS	$-7.1	$-2.29	$-1.89
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-1371.7M	$-453.82M	$-364.89M
Operating Income / Loss	$-1386.83M	$-445.22M	$-361.63M
Cost of Revenue
Net Cash Flow	$108.55M	$57.19M	$166.3M
PE Ratio